But Stryker's stock dipped over 2%, as Wall Street wrestled with the $80-per-share valuation and questions about short-term ...

Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion. Inari stock catapulted Tuesday on the news.

Fintel reports that on January 7, 2025, William Blair downgraded their outlook for Inari Medical (NasdaqGS:NARI) from ...

Inari Medical (NARI – Research Report) received a Hold rating and price target from BTIG analyst Marie Thibault today. The company’s shares ...

Canaccord Genuity Group reiterated their hold rating on shares of Inari Medical (NASDAQ:NARI – Free Report) in a research ...

Inari Medical (NARI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Sarcone ...

Wells Fargo & Company reaffirmed their equal weight rating on shares of Inari Medical (NASDAQ:NARI – Free Report) in a report issued on Tuesday,Benzinga reports. The firm currently has a $80.00 price ...

After professing a hearty appetite for tuck-in M&A last year and signing a string of smaller deals, Stryker is now opening ...

Medical-device maker Stryker has agreed to acquire Inari Medical, which makes devices that treat patients with venous ...

Portage: Stryker, a medical technologies company, has announced a definitive agreement to acquire all of the issued and ...

Air pollution raises venous thromboembolism risk. Study highlights pollutants’ impact on vascular health and public policy.